American Association of Endocrine Surgeons| Volume 128, ISSUE 6, P1007-1012, December 2000

Download started.


Pheochromocytoma: Inherited associations, bilaterality, and cortex preservation


      Background. Hereditary pheochromocytoma (HP) is characterized by early onset, bilateral adrenal involvement, low malignancy rate, and genetic linkage with certain familial syndromes. This retrospective review is intended to show the high yield of surveillance, predictable bilaterality, and the challenge of cortex-sparing adrenalectomy. Methods. From 1964 to 1999, 32 patients with HP were treated at a single institution and followed for a mean of 7 years. There were 15 cases of multiple endocrine neoplasia type 2A (MEN 2A), 12 cases of von Hippel-Lindau (VHL) disease, 3 cases of von Recklinghausen's disease (VRD), and 2 cases of familial pheochromocytoma. Twenty-four of 32 patients underwent bilateral adrenalectomy (9 metachronous). Subtotal resection with orthotopic cortex preservation was performed in 5 patients, and heterotopic autografting was performed in 14 patients. Results. Pheochromocytoma was the first manifestation in 50% of patients with VHL disease and in 27% of patients with MEN 2A. Surveillance uncovered medullary thyroid cancer in 5 of 15 patients with MEN 2A and hemangioblastomas, renal cell carcinoma, and islet cell tumors in 7 of 15 patients with VHL disease and VRD. HP was bilateral in 24 of 32 patients (14/15 in patients with MEN 2A, 7/12 in patients with VHL disease, 2/3 in patients with VRD, and 1/2 in patients with familial pheochromocytoma). In 9 cases of metachronous adrenalectomy, the mean interval was 67 months (range, 9-156 months). Three of 5 patients who underwent orthotopic preservation of the adrenal cortex experienced recurrence compared with 0 of 14 patients with heterotopic autotransplantation of cortical tissue. Conclusions. Pheochromocytoma frequently heralds coexisting silent VHL disease or MEN-2, mandating surveillance for inherited associations. The long interval of metachronous pheochromocytoma argues against prophylactic removal of the contralateral “normal” adrenal gland. Total adrenalectomy and heterotopic autotransplantation of medulla-free cortex may diminish the need for lifelong steroid substitution and eliminates recurrence. (Surgery 2000;128:1007-12.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Neumann HPH
        • Berger DP
        • Sigmund G
        • et al.
        Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
        N Engl J Med. 1993; 329: 1531-1538
        • Grant CS
        in: Textbook of endocrine surgery. : Saunders, Philadelphia1997: 513-522
        • Choyke PL
        • Glenn GM
        • Walther MM
        • Patronas NJ
        • Linehan WM
        • Zbar B
        von Hippel-Lindau disease: genetic, clinical, and imaging features.
        Radiology. 1995; 194: 629-642
        • Webb TA
        • Sheps SG
        • Carney JA
        Differences between sporadic pheochromocytoma and pheochromocytoma in multiple endocrine neoplasia type 2.
        Am J Surg Pathol. 1980; 4: 121-126
        • Richard S
        • Beigelman C
        • Duclos JM
        • et al.
        Pheochromocytoma as the first manifestation of von Hippel-Lindau disease.
        Surgery. 1994; 116: 1076-1081
        • Neumann HPH
        • Bender BU
        • Reincke M
        • Eggstein S
        • Laubenberger J
        • Kirste G
        Adrenal-sparing surgery for pheochromocytoma.
        Br J Surg. 1999; 86: 94-97
        • Lee JE
        • Curley SA
        • Gagel RF
        • Evans DB
        • RC Hickey
        Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma.
        Surgery. 1996; 120: 1064-1071
        • Okamato T
        • Obara T
        • Ito Y
        • et al.
        Bilateral adrenalectomy with autotransplantation of adrenalcortical tissue or unilateral adrenalectomy: treatment options for pheochromocytoma in multiple endocrine neoplasia type 2A.
        Endocr J. 1996; 43: 169-175
        • Ott R
        • Calandra D
        • Prinz R
        • Brooks MH
        • Lawrence AM
        • Paloyan E
        Successful adrenal autotransplantation in Cushing's disease.
        Surgery. 1984; 96: 1054-1060
        • Miyauchi A
        • Kihara M
        • Matasusaka A
        • Nishiyama Y
        Successful autotransplantation of an adrenal gland using a new method of omental wrapping: report of a case.
        Surg Today. 1999; 29: 960-962
        • Demeter JG
        • De Jong SA
        • Brooks MH
        • Lawrence AM
        • Paloyan E
        Long-term results of adrenal autotransplantation in Cushing's disease.
        Surgery. 1990; 108: 1117-1123
        • Walther MM
        • Reiter R
        • Keiser HR
        • et al.
        Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma.
        J Urol. 1999; 162: 659-664
        • Maher ER
        • Kaelin WG
        Reviews in molecular medicine: von Hippel-Lindau disease.
        Medicine. 1997; 76: 381-391
        • Gutman DH
        • Aylsworth A
        • Carey JC
        • et al.
        The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.
        JAMA. 1997; 278: 51-57
        • Walther MM
        • Herring J
        • Enquist E
        • Keiser HR
        • Linehan WM
        von Recklinghausen's disease and pheochromocytomas.
        J Urol. 1999; 162: 1582-1586
        • van Heerden JA
        • Sizemore GW
        • Carney JA
        • et al.
        Surgical management of the adrenal glands in multiple endocrine neoplasia type II syndrome.
        World J Surg. 1984; 8: 612-618
        • Neumann HPH
        • Reincke M
        • Bender BU
        • Elsner R
        • Janetschek G
        Preserved adrenocortical function after laparoscopic bilateral adrenal sparing surgery for hereditary pheochromocytoma.
        J Clin Endocrinol Metab. 1999; 84: 2608-2610
        • Hardy JD
        • Moore DO
        • Langford HG
        Cushing's disease today: late follow-up of 17 adrenalectomy patients with emphasis on eight with adrenal autotransplants.
        Ann Surg. 1985; 201: 595-603
        • Mulligan LM
        • Kwok JBJ
        • Healey CS
        • et al.
        Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
        Nature. 1993; 363: 458-460
        • Latif F
        • Tory K
        • Gnarra J
        • et al.
        Identification of the von Hippel-Lindau disease tumor suppressor gene.
        Science. 1993; 260: 1317-1320
        • Atuk NO
        • Stolle C
        • Owen JA
        • Carpenter JT
        • Vance ML
        Pheochromocytoma in von Hippel-Lindau disease: clinical presentation and mutation analysis in a large, multigenerational kindred.
        J Clin Endocrinol Metab. 1998; 83: 117-120